Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells

Tumor progression and metastasis may result in part from the selection of cell clones competent for survival, invasion and growth at secondary sites acid characterized by loss of growth inhibitory responses, acquisition of increased adhesiveness and enhanced motility and protease expression. Transforming growth factor-beta 1 (TGF-beta 1) is produced by osteoblasts (OB) in a latent form and is activated by proteases in a cell-dependent manner, We show here that OB conditioned medium (OB CM) modulates Matrigel invasion of a bone metastatic prostate cancer cell line (PC3) and that this effect is blocked by antibody against TGF-beta 1 and by uPA/plasmin inhibitors, suggesting that TGF-beta 1 can modulate OB-mediated cell recruitment and that PC3 cells can activate TGF-beta 1. TGF-beta 1 induces uPA and PAI-I secretion and promotes binding of uPA at the external plasma membrane with increased membrane-associated plasmin activity. Matrix metalloprotease-9 (MMP-9) is induced both in the medium and in the membrane associated form. Moreover, the balance between proteolytic activity and inhibition is crucial in the metastatic event. Indeed, the increment of PAI-I could have an important regulatory role on the extracellular proteolysis and might explain the decrease of net PA and gelatinolytic activities measured in the medium. In addition, PAI-I plays a regulative role localizing matrix degradation in some specific sites, such as areas of cell-to-cell or cell-to-ECM contacts. In conclusion, TGF-beta 1 enhances PC3 Matrigel invasion by a uPA/plasmin-dependent mechanism, also involving the MMP-9, and thus may play a central role in malignant prostate tumor progression as a result of stimulating bone matrix invasion. (C) 2000 Wiley-Liss, Inc.